• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT POINT OF CARE I-STAT PT/INR CARTRIDGE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT POINT OF CARE I-STAT PT/INR CARTRIDGE Back to Search Results
Catalog Number 03P89-24
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problems Stroke/CVA (1770); High Blood Pressure/ Hypertension (1908); Myocardial Infarction (1969); Pain (1994); Respiratory Failure (2484)
Event Date 08/27/2019
Event Type  malfunction  
Manufacturer Narrative
Apoc incident # (b)(4).Apoc labeling will be evaluated during the investigation as pertaining to the event.
 
Event Description
On (b)(6) 2019, abbott point of care was contacted by a customer regarding i-stat pt/inr cartridges that yielded a suspected discrepant pt/inr result of 47.3/4.2 on a (b)(6) year old male that arrived at the hospital intubated; non responsive and with an active gi bleed.There was no additional patient information available at the time of this report.Return product is available for investigation.(b)(6).At this time there is no reason to suspect a malfunction exists.The reporting decision was based on limited information available that suggests the product was not performing within the variability of the assay.The customer states that the patient is not on coumadin or warfarin.It was determined that the customer is not using i-stat pt/inr for its intended use.Per 715236-00s, the i-stat pt, a prothrombin time test, is useful for monitoring patients receiving oral anticoagulation therapy such as coumadin or warfarin.The customer also stated that the patient received fresh frozen plasma based on the i-stat result.Based on the information given that patient may have been unnecessarily transfused.This is an adverse event.The investigation is underway.
 
Manufacturer Narrative
Apoc incident # (b)(4).The investigation was completed on 09/25/2019.A review of the device history record confirmed that the cartridge lot passed release specifications.Retained and returned cartridge testing met the acceptance criteria outlined in appendix 1 of q04.01.003 rev.Ad (product complaint level 2 and level 3 investigation procedure).No deficiency has been identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
I-STAT PT/INR CARTRIDGE
Type of Device
PT/INR CARTRIDGE
Manufacturer (Section D)
ABBOTT POINT OF CARE
400 college road
princeton NJ 08540 6607
MDR Report Key9077647
MDR Text Key169918735
Report Number2245578-2019-00218
Device Sequence Number1
Product Code GJS
UDI-Device Identifier10054749000170
UDI-Public10054749000170
Combination Product (y/n)N
PMA/PMN Number
K020355
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 10/02/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/17/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/29/2019
Device Catalogue Number03P89-24
Device Lot NumberS19183A
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/09/2019
Date Manufacturer Received09/25/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age66 YR
-
-